{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:42:53Z","timestamp":1782996173037,"version":"3.54.5"},"reference-count":101,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T00:00:00Z","timestamp":1524960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M006824\/1"],"award-info":[{"award-number":["MR\/M006824\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The neuromuscular junction is the point of contact between motor nerve and skeletal muscle, its vital role in muscle function is reliant on the precise location and function of many proteins. Congenital myasthenic syndromes (CMS) are a heterogeneous group of disorders of neuromuscular transmission with 30 or more implicated proteins. The use of animal models has been instrumental in determining the specific role of many CMS-related proteins. The mouse neuromuscular junction (NMJ) has been extensively studied in animal models of CMS due to its amenability for detailed electrophysiological and histological investigations and relative similarity to human NMJ. As well as their use to determine the precise molecular mechanisms of CMS variants, where an animal model accurately reflects the human phenotype they become useful tools for study of therapeutic interventions. Many of the animal models that have been important in deconvolving the complexities of neuromuscular transmission and revealing the molecular mechanisms of disease are highlighted.<\/jats:p>","DOI":"10.3390\/ijms19051326","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T03:45:49Z","timestamp":1525059949000},"page":"1326","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes"],"prefix":"10.3390","volume":"19","author":[{"given":"Richard G.","family":"Webster","sequence":"first","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/WCO.0000000000000134","article-title":"Congenital myasthenic syndromes and the neuromuscular junction","volume":"27","author":"Palace","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3233\/JND-170257","article-title":"Congenital myasthenic syndromes or inherited disorders of neuromuscular transmission: Recent discoveries and open questions","volume":"4","author":"Nicole","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/hmg\/ddh320","article-title":"A mouse model of achr deficiency syndrome with a phenotype reflecting the human condition","volume":"13","author":"Cossins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1097-4598(199601)19:1<79::AID-MUS11>3.0.CO;2-Z","article-title":"A transgenic mouse model of the slow-channel syndrome","volume":"19","author":"Gomez","year":"1996","journal-title":"Muscle Nerve"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1523\/JNEUROSCI.17-11-04170.1997","article-title":"Slow-channel transgenic mice: A model of postsynaptic organellar degeneration at the neuromuscular junction","volume":"17","author":"Gomez","year":"1997","journal-title":"J. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1523\/JNEUROSCI.22-15-06447.2002","article-title":"Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome","volume":"22","author":"Gomez","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JND-170226","article-title":"A panel of slow-channel congenital myasthenic syndrome mice reveals a unique locomotor behavioral signature","volume":"4","author":"Quesada","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.nbd.2011.10.024","article-title":"A new mouse model for the slow-channel congenital myasthenic syndrome induced by the achr epsilonl221f mutation","volume":"45","author":"Chevessier","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2013.06.012","article-title":"A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment","volume":"248","author":"Webster","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.nbd.2006.04.018","article-title":"Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model","volume":"23","author":"Vohra","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1172\/JCI30383","article-title":"Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome","volume":"117","author":"Groshong","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.expneurol.2014.10.008","article-title":"Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome","volume":"270","author":"Zhu","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1093\/hmg\/ddn251","article-title":"A mouse model for congenital myasthenic syndrome due to musk mutations reveals defects in structure and function of neuromuscular junctions","volume":"17","author":"Chevessier","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuron.2016.10.023","article-title":"Enzymatic activity of the scaffold protein rapsyn for synapse formation","volume":"92","author":"Li","year":"2016","journal-title":"Neuron"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.1250744","article-title":"Neuromuscular disease. Dok7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction","volume":"345","author":"Arimura","year":"2014","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1093\/hmg\/ddr396","article-title":"A valid mouse model of agrin-associated congenital myasthenic syndrome","volume":"20","author":"Bogdanik","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.expneurol.2015.01.007","article-title":"Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models","volume":"270","author":"Plomp","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Deacon, R.M. (2013). Measuring the strength of mice. J. Vis. Exp.","DOI":"10.3791\/2610"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"24849","DOI":"10.1038\/srep24849","article-title":"Age-related fragmentation of the motor endplate is not associated with impaired neuromuscular transmission in the mouse diaphragm","volume":"6","author":"Willadt","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<367::AID-SYN10>3.0.CO;2-P","article-title":"Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents","volume":"27","author":"Bhattacharyya","year":"1997","journal-title":"Synapse"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1523\/JNEUROSCI.03-03-00644.1983","article-title":"Fine structural distribution of acetylcholine receptors at developing mouse neuromuscular junctions","volume":"3","author":"Salpeter","year":"1983","journal-title":"J. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s00415-014-7520-7","article-title":"Inherited disorders of the neuromuscular junction: An update","volume":"261","author":"Palace","year":"2014","journal-title":"J. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: Pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0014-5793(87)80518-5","article-title":"Differential regulation of muscle acetylcholine receptor gamma- and epsilon-subunit mrnas","volume":"223","author":"Witzemann","year":"1987","journal-title":"FEBS Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/344544a0","article-title":"Imprinting of acetylcholine receptor messenger rna accumulation in mammalian neuromuscular synapses","volume":"344","author":"Brenner","year":"1990","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13286","DOI":"10.1073\/pnas.93.23.13286","article-title":"Acetylcholine receptor epsilon-subunit deletion causes muscle weakness and atrophy in juvenile and adult mice","volume":"93","author":"Witzemann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1242\/dev.124.24.5075","article-title":"Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an \u2018adult\u2019 acetylcholine receptor subunit","volume":"124","author":"Missias","year":"1997","journal-title":"Development"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/124.7.1362","article-title":"End-plate gamma- and epsilon-subunit mrna levels in achr deficiency syndrome due to epsilon-subunit null mutations","volume":"124","author":"Croxen","year":"2001","journal-title":"Brain"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/aws016","article-title":"A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance","volume":"135","author":"Webster","year":"2012","journal-title":"Brain"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2007.06.031","article-title":"Rapsyn interaction with calpain stabilizes achr clusters at the neuromuscular junction","volume":"55","author":"Chen","year":"2007","journal-title":"Neuron"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1212\/01.WNL.0000061483.11417.1B","article-title":"Treatment of slow-channel congenital myasthenic syndrome with fluoxetine","volume":"60","author":"Harper","year":"2003","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1523\/JNEUROSCI.17-15-05651.1997","article-title":"Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the m2 domain of the acetylcholine receptor alpha subunit","volume":"17","author":"Milone","year":"1997","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase musk is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(00)81252-0","article-title":"Agrin acts via a musk receptor complex","volume":"85","author":"Glass","year":"1996","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1242\/dev.02696","article-title":"Ldl-receptor-related protein 4 is crucial for formation of the neuromuscular junction","volume":"133","author":"Weatherbee","year":"2006","journal-title":"Development"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for agrin and forms a complex with musk","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"Lrp4 serves as a coreceptor of agrin","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/35074025","article-title":"Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse","volume":"410","author":"Lin","year":"2001","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0896-6273(01)00287-2","article-title":"Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation","volume":"30","author":"Yang","year":"2001","journal-title":"Neuron"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nn2026","article-title":"Musk controls where motor axons grow and form synapses","volume":"11","author":"Kim","year":"2008","journal-title":"Nat. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1523\/JNEUROSCI.5080-07.2008","article-title":"Evidence for muscle-dependent neuromuscular synaptic site determination in mammals","volume":"28","author":"Vock","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-6606-5-7","article-title":"Wnt proteins regulate acetylcholine receptor clustering in muscle cells","volume":"5","author":"Zhang","year":"2012","journal-title":"Mol. Brain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/dneu.22190","article-title":"Crosstalk between agrin and wnt signaling pathways in development of vertebrate neuromuscular junction","volume":"74","author":"Barik","year":"2014","journal-title":"Dev. Neurobiol."},{"key":"ref_44","first-page":"1712","article-title":"Wnt proteins contribute to neuromuscular junction formation through distinct signaling pathways","volume":"144","author":"Messeant","year":"2017","journal-title":"Development"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0896-6273(90)90079-U","article-title":"The postsynaptic 43k protein clusters muscle nicotinic acetylcholine receptors in xenopus oocytes","volume":"5","author":"Froehner","year":"1990","journal-title":"Neuron"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1083\/jcb.115.6.1713","article-title":"Mutagenesis of the 43-kd postsynaptic protein defines domains involved in plasma membrane targeting and achr clustering","volume":"115","author":"Phillips","year":"1991","journal-title":"J. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/377232a0","article-title":"Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice","volume":"377","author":"Gautam","year":"1995","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/339465","article-title":"Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome","volume":"70","author":"Ohno","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/brain\/awl219","article-title":"Diverse molecular mechanisms involved in achr deficiency due to rapsyn mutations","volume":"129","author":"Cossins","year":"2006","journal-title":"Brain"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/brain\/awl188","article-title":"Chrnd mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn","volume":"129","author":"Baumeister","year":"2006","journal-title":"Brain"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.1127142","article-title":"The muscle protein dok-7 is essential for neuromuscular synaptogenesis","volume":"312","author":"Okada","year":"2006","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1130837","article-title":"Dok-7 mutations underlie a neuromuscular junction synaptopathy","volume":"313","author":"Beeson","year":"2006","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awm072","article-title":"Clinical features of the dok7 neuromuscular junction synaptopathy","volume":"130","author":"Palace","year":"2007","journal-title":"Brain"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"880","DOI":"10.15252\/emmm.201607298","article-title":"Dok7 gene therapy enhances motor activity and life span in als model mice","volume":"9","author":"Miyoshi","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1101\/gad.1977710","article-title":"Dok-7 regulates neuromuscular synapse formation by recruiting crk and crk-l","volume":"24","author":"Hallock","year":"2010","journal-title":"Genes Dev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0301-0082(93)90040-Y","article-title":"Molecular and cellular biology of cholinesterases","volume":"41","author":"Massoulie","year":"1993","journal-title":"Prog. Neurobiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn801","article-title":"Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice","volume":"5","author":"Rossi","year":"2002","journal-title":"Nat. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1074\/jbc.272.5.3016","article-title":"Quaternary associations of acetylcholinesterase. Ii. The polyproline attachment domain of the collagen tail","volume":"272","author":"Bon","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"9654","DOI":"10.1073\/pnas.95.16.9654","article-title":"Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (COLQ) of the asymmetric enzyme","volume":"95","author":"Ohno","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1086\/302059","article-title":"Mutation in the human acetylcholinesterase-associated collagen gene, colq, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (type ic)","volume":"63","author":"Donger","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1083\/jcb.144.6.1349","article-title":"Genetic analysis of collagen q: Roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function","volume":"144","author":"Feng","year":"1999","journal-title":"J. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"11870","DOI":"10.1523\/JNEUROSCI.0329-14.2014","article-title":"Schwann cells sense and control acetylcholine spillover at the neuromuscular junction by alpha7 nicotinic receptors and butyrylcholinesterase","volume":"34","author":"Petrov","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1096\/fj.201500162","article-title":"Neuromuscular junction immaturity and muscle atrophy are hallmarks of the colq-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency","volume":"30","author":"Sigoillot","year":"2016","journal-title":"FASEB J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1083\/jcb.105.6.2471","article-title":"Identification of agrin, a synaptic organizing protein from torpedo electric organ","volume":"105","author":"Nitkin","year":"1987","journal-title":"J. Cell Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1083\/jcb.99.2.615","article-title":"Components of torpedo electric organ and muscle that cause aggregation of acetylcholine receptors on cultured muscle cells","volume":"99","author":"Godfrey","year":"1984","journal-title":"J. Cell Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0092-8674(00)81253-2","article-title":"Defective neuromuscular synaptogenesis in agrin-deficient mutant mice","volume":"85","author":"Gautam","year":"1996","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajhg.2009.06.015","article-title":"Identification of an agrin mutation that causes congenital myasthenia and affects synapse function","volume":"85","author":"Huze","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00439-011-1132-4","article-title":"Lg2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin","volume":"131","author":"Maselli","year":"2012","journal-title":"Hum. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/dneu.20953","article-title":"Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction","volume":"71","author":"Singhal","year":"2011","journal-title":"Dev. Neurobiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/hmg\/ddh284","article-title":"Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities","volume":"13","author":"Zenker","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/374258a0","article-title":"Aberrant differentiation of neuromuscular junctions in mice lacking s-laminin\/laminin beta 2","volume":"374","author":"Noakes","year":"1995","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2008.063693","article-title":"Mutations in lamb2 causing a severe form of synaptic congenital myasthenic syndrome","volume":"46","author":"Maselli","year":"2009","journal-title":"J. Med. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"12230","DOI":"10.1523\/JNEUROSCI.5518-09.2010","article-title":"Muscle-derived collagen xiii regulates maturation of the skeletal neuromuscular junction","volume":"30","author":"Latvanlehto","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1093\/hmg\/ddx101","article-title":"Collagen xiii secures pre- and postsynaptic integrity of the neuromuscular synapse","volume":"26","author":"Haronen","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ajhg.2015.10.017","article-title":"Congenital myasthenic syndrome type 19 is caused by mutations in col13a1, encoding the atypical non-fibrillar collagen type xiii alpha1 chain","volume":"97","author":"Logan","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2007.02.035","article-title":"Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals","volume":"129","author":"Fox","year":"2007","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1242\/jcs.201103","article-title":"Multiple roles of integrin-alpha3 at the neuromuscular junction","volume":"130","author":"Ross","year":"2017","journal-title":"J. Cell Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1242\/dev.122.11.3537","article-title":"Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis","volume":"122","author":"Kreidberg","year":"1996","journal-title":"Development"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa1110813","article-title":"Integrin alpha3 mutations with kidney, lung, and skin disease","volume":"366","author":"Has","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1073\/pnas.98.4.2017","article-title":"Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans","volume":"98","author":"Ohno","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0896-6273(02)01020-6","article-title":"Roles of neurotransmitter in synapse formation: Development of neuromuscular junctions lacking choline acetyltransferase","volume":"36","author":"Misgeld","year":"2002","journal-title":"Neuron"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1523\/JNEUROSCI.23-02-00539.2003","article-title":"Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice","volume":"23","author":"Brandon","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajhg.2014.08.007","article-title":"Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy","volume":"95","author":"Herrmann","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1212\/WNL.0000000000002185","article-title":"Electrophysiologic features of syt2 mutations causing a treatable neuromuscular syndrome","volume":"85","author":"Whittaker","year":"2015","journal-title":"Neurology"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Shields, M.C., Bowers, M.R., Fulcer, M.M., Bollig, M.K., Rock, P.J., Sutton, B.R., Vrailas-Mortimer, A.D., Lochmuller, H., Whittaker, R.G., and Horvath, R. (2017). Drosophila studies support a role for a presynaptic synaptotagmin mutation in a human congenital myasthenic syndrome. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184817"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.24905","article-title":"Homozygous mutations in vamp1 cause a presynaptic congenital myasthenic syndrome","volume":"81","author":"Salpietro","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-006-0068-7","article-title":"A null mutation in vamp1\/synaptobrevin is associated with neurological defects and prewean mortality in the lethal-wasting mouse mutant","volume":"8","author":"Nystuen","year":"2007","journal-title":"Neurogenetics"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/IJGM.S88552","article-title":"Animal models of myasthenia gravis: Utility and limitations","volume":"9","author":"Mantegazza","year":"2016","journal-title":"Int. J. Gen. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroscience.2018.01.042","article-title":"Introducing autoimmunity at the synapse by a novel animal model of experimental autoimmune myasthenia gravis","volume":"374","author":"Wang","year":"2018","journal-title":"Neuroscience"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/nyas.13555","article-title":"Acetylcholine receptor antibody-mediated animal models of myasthenia gravis and the role of complement","volume":"1413","author":"Kusner","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/nyas.13507","article-title":"Neuromuscular synapse electrophysiology in myasthenia gravis animal models","volume":"1412","author":"Plomp","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of musk-ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis igg4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/08820139.2017.1299754","article-title":"Immunization with recombinantly expressed lrp4 induces experimental autoimmune myasthenia gravis in c57bl\/6 mice","volume":"46","author":"Ulusoy","year":"2017","journal-title":"Immunol. Investig."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.expneurol.2017.08.006","article-title":"Immunization of mice with lrp4 induces myasthenia similar to musk-associated myasthenia gravis","volume":"297","author":"Mori","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1113\/jphysiol.1992.sp019429","article-title":"Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats","volume":"458","author":"Plomp","year":"1992","journal-title":"J. Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","article-title":"Pyridostigmine but not 3,4-diaminopyridine exacerbates ach receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody","volume":"591","author":"Morsch","year":"2013","journal-title":"J. Physiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2741\/4532","article-title":"Trans-synaptic homeostasis at the myasthenic neuromuscular junction","volume":"22","author":"Plomp","year":"2017","journal-title":"Front. Biosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1523\/JNEUROSCI.1789-17.2018","article-title":"Muscle nicotinic acetylcholine receptors may mediate trans-synaptic signaling at the mouse neuromuscular junction","volume":"38","author":"Wang","year":"2018","journal-title":"J. Neurosci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/5\/1326\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:02:39Z","timestamp":1760194959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/5\/1326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,29]]},"references-count":101,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["ijms19051326"],"URL":"https:\/\/doi.org\/10.3390\/ijms19051326","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,29]]}}}